Thesis (Ph.D.)--University of Washington, 2018Background: An estimated 200,000 deaths due to rotavirus diarrhea occur annually in children with most of the burden in low-income settings. Rotavirus is a double stranded RNA virus transmitted via the fecal-oral route. Without a vaccine, nearly all children <5 years old become infected with rotavirus and recurrent infection is common. Rotavirus vaccines continue to be the key intervention needed to reduce the global burden of severe rotavirus diarrhea. Two rotavirus vaccines are used worldwide (Rotarix [RV1]) and (RotaTeq [RV5]). Large multi-site randomized controlled trials (RCTs) of both vaccines in sub-Saharan Africa and Asia demonstrated moderate vaccine efficacy (VE) against severe rotavir...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
INTRODUCTION:Globally, rotavirus (RV) is the leading cause of gastroenteritis (GE) in children. Long...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
Thesis (Ph.D.)--University of Washington, 2018Background: An estimated 200,000 deaths due to rotavir...
Thesis (Master's)--University of Washington, 2020Background: Rotavirus causes around 329,000 diarrhe...
Rotavirus claims thousands of lives of children globally every year with a disproportionately high b...
Rotavirus is the leading cause of severe diarrhea among children<5 years worldwide. Currently licens...
INTRODUCTION: Rotavirus vaccine efficacy ranges from >90% in high socio-economic settings (SES) to 5...
BACKGROUND: Rotavirus gastroenteritis is the leading cause of diarrheal disease mortality among chil...
AbstractBackgroundThe test-negative design (TND), an epidemiologic method currently used to measure ...
Rotavirus is the leading cause of diarrheal death among children\ua0\ua065% of children had at least...
Background:Rotavirus is the leading cause of severe diarrhea among young children worldwide. Rotavir...
In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination on hos...
Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 201...
Rotavirus vaccines have been introduced into over 95 countries globally and demonstrate substantial ...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
INTRODUCTION:Globally, rotavirus (RV) is the leading cause of gastroenteritis (GE) in children. Long...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
Thesis (Ph.D.)--University of Washington, 2018Background: An estimated 200,000 deaths due to rotavir...
Thesis (Master's)--University of Washington, 2020Background: Rotavirus causes around 329,000 diarrhe...
Rotavirus claims thousands of lives of children globally every year with a disproportionately high b...
Rotavirus is the leading cause of severe diarrhea among children<5 years worldwide. Currently licens...
INTRODUCTION: Rotavirus vaccine efficacy ranges from >90% in high socio-economic settings (SES) to 5...
BACKGROUND: Rotavirus gastroenteritis is the leading cause of diarrheal disease mortality among chil...
AbstractBackgroundThe test-negative design (TND), an epidemiologic method currently used to measure ...
Rotavirus is the leading cause of diarrheal death among children\ua0\ua065% of children had at least...
Background:Rotavirus is the leading cause of severe diarrhea among young children worldwide. Rotavir...
In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination on hos...
Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 201...
Rotavirus vaccines have been introduced into over 95 countries globally and demonstrate substantial ...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...
INTRODUCTION:Globally, rotavirus (RV) is the leading cause of gastroenteritis (GE) in children. Long...
Oral rotavirus vaccine efficacy is lower in low- and middle-income countries (LMICs) than in high-in...